Evaluation and management of psoriatic arthritis: the role of biologic therapy
- 1 August 2003
- journal article
- review article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 49 (2) , 125-132
- https://doi.org/10.1016/s0190-9622(03)01145-9
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Treatment of psoriatic arthritis with antitumour necrosis factor-α antibody clears skin lesions of psoriasis resistant to treatment with methotrexateBritish Journal of Dermatology, 2001
- Psoriatic arthritisExpert Opinion on Investigational Drugs, 2000
- SULPHASALAZINE IN PSORIATIC ARTHRITIS: A RANDOMIZED, MULTICENTRE, PLACEBO-CONTROLLED STUDYRheumatology, 1996
- Tumour necrosis factor alpha is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expressionBritish Journal of Dermatology, 1995
- The Cytokine Network in Lesional and Lesion-Free Psoriatic Skin Is Characterized by a T-Helper Type 1 Cell-Mediated ResponseJournal of Investigative Dermatology, 1993
- Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytesCell, 1989
- Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal inflamed skin: Modulation by recombinant gamma interferon and tumor necrosis factorJournal of the American Academy of Dermatology, 1989
- Exacerbation of psoriasis by indomethacinBritish Journal of Dermatology, 1987
- Juvenile psoriatic arthritis—an analysis of 60 casesThe Journal of Pediatrics, 1982
- Psoriatic ArthritisAnnals of the Rheumatic Diseases, 1961